Discover open access scientific publications

Search, annotate, share and cite publications

Publications by R. N. Jones

Determination of Disk Diffusion and MIC Quality Control Guidelines for JNJ-Q2, a Novel Quinolone

Journal of Clinical Microbiology

Microbiology

2011

English

Use of Molecular and Reference Susceptibility Testing Methods in a Multicenter Evaluation of MicroScan Dried Overnight Gram-Positive MIC Panels for Detection of Vancomycin and High-Level Aminoglycoside Resistances in Enterococci

Journal of Clinical Microbiology

Microbiology

1998

English

Quality Control Guidelines for BAL9141 (Ro 63-9141), an Investigational Cephalosporin, When Reference MIC and Standardized Disk Diffusion Susceptibility Test Methods Are Used

Journal of Clinical Microbiology

Microbiology

2004

English

Quality Control Guidelines for MIC Susceptibility Testing of Omiganan Pentahydrochloride (MBI 226), a Novel Antimicrobial Peptide

Journal of Clinical Microbiology

Microbiology

2004

English

Characterization of Vancomycin-Heteroresistant Staphylococcus Aureus From the Metropolitan Area of Detroit, Michigan, Over a 22-Year Period (1986 to 2007)

Journal of Clinical Microbiology

Microbiology

2008

English

International Surveillance of Bloodstream Infections Due to Candida Species: Frequency of Occurrence and in Vitro Susceptibilities to Fluconazole, Ravuconazole, and Voriconazole of Isolates Collected From 1997 Through 1999 in the SENTRY Antimicrobial Surveillance Program

Journal of Clinical Microbiology

Microbiology

2001

English

Comparison of in Vitro Antimicrobial Activity of Cefamandole and Cefazolin With Cephalothin Against Over 8,000 Clinical Bacterial Isolates

Antimicrobial Agents and Chemotherapy

Infectious Diseases

Pharmacology

1976

English

Pharmacokinetics-Pharmacodynamics of Cefepime and Piperacillin- Tazobactam Against Escherichia Coli and Klebsiella Pneumoniae Strains Producing Extended-Spectrum -Lactamases: Report From the ARREST Program

Antimicrobial Agents and Chemotherapy

Infectious Diseases

Pharmacology

2003

English

In Vitro Activities of Posaconazole (Sch 56592) Compared With Those of Itraconazole and Fluconazole Against 3,685 Clinical Isolates of Candida Spp. And Cryptococcus Neoformans

Antimicrobial Agents and Chemotherapy

Infectious Diseases

Pharmacology

2001

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by R. N. Jones

Determination of Disk Diffusion and MIC Quality Control Guidelines for JNJ-Q2, a Novel Quinolone

Use of Molecular and Reference Susceptibility Testing Methods in a Multicenter Evaluation of MicroScan Dried Overnight Gram-Positive MIC Panels for Detection of Vancomycin and High-Level Aminoglycoside Resistances in Enterococci

Quality Control Guidelines for BAL9141 (Ro 63-9141), an Investigational Cephalosporin, When Reference MIC and Standardized Disk Diffusion Susceptibility Test Methods Are Used

Quality Control Guidelines for MIC Susceptibility Testing of Omiganan Pentahydrochloride (MBI 226), a Novel Antimicrobial Peptide

Characterization of Vancomycin-Heteroresistant Staphylococcus Aureus From the Metropolitan Area of Detroit, Michigan, Over a 22-Year Period (1986 to 2007)

International Surveillance of Bloodstream Infections Due to Candida Species: Frequency of Occurrence and in Vitro Susceptibilities to Fluconazole, Ravuconazole, and Voriconazole of Isolates Collected From 1997 Through 1999 in the SENTRY Antimicrobial Surveillance Program

Comparison of in Vitro Antimicrobial Activity of Cefamandole and Cefazolin With Cephalothin Against Over 8,000 Clinical Bacterial Isolates

Pharmacokinetics-Pharmacodynamics of Cefepime and Piperacillin- Tazobactam Against Escherichia Coli and Klebsiella Pneumoniae Strains Producing Extended-Spectrum -Lactamases: Report From the ARREST Program

In Vitro Activities of Posaconazole (Sch 56592) Compared With Those of Itraconazole and Fluconazole Against 3,685 Clinical Isolates of Candida Spp. And Cryptococcus Neoformans